Aeon 的最新消息
@the_transit_guy @glasser When masks were required it said so, and if you can find the odd place that does it probably still says that.
But it doesn't say "masks not required". It does still say things like "contact free pickup" and such.
@当需要戴口罩时,glasser的“运输人”说是这样的,如果你能找到一个奇怪的地方,它可能仍然这么说。
但它并没有说“不需要戴口罩”。它仍然会说“无接触皮卡”之类的话。
@greg_travis @hjelle_brian That make no sense. The blue chart is infections, right?
And it's interesting that even the background rate before the omicron surge was much higher (due to lingering/migrating delta surge I guess)
@greg_travis@hjelle_brian这毫无意义。蓝色图表是感染,对吗?
有趣的是,即使是在omicron激增之前,背景频率也要高得多(我猜是由于延迟/迁移的三角洲激增)
@greg_travis @hjelle_brian I don't either, just that 100x is a big difference. Takes a lot to offset that. We're not seeing it subjective either. During the peak people were getting infected right and left. Every small social circle had people sick. Now they're not, to the same extent.
@greg_travis@hjelle_brian我也不知道,只是100倍是一个很大的区别。要抵消这一点需要很多。我们也不认为这是主观的。在高峰期,人们左右都受到感染。每个小圈子都有人生病。但现在,它们的程度不同了。
@greg_travis @hjelle_brian Prevalence was probably 100x higher some places at peak vs. now. The usual masks people wear aren't 99% effective, so this is probably not correct. But the point of risk compensation and the risk also not being 100x lower is valid.
@greg_travis@hjelle_brian的患病率可能比现在高出100倍。人们通常戴的口罩没有99%的效果,所以这可能是不正确的。但风险补偿点和风险不低于100倍的点是有效的。
@jmcrookston https://twitter.com/AeonCoin/s...
@watermelonpunch "Everyone" getting in infected is all the more reason to wait it out. My evergreen response to "everyone will get it" is "you go first".
发表时间:4年前 作者:aeon @AeonCoin@杰姆克鲁克斯顿https://twitter.com/AeonCoin/s...
@西瓜汁“每个人”都被感染了,这更是我们等待它结束的理由。我对“每个人都会得到”的回应是“你先走”。
@dgurdasani1 @AbundantLandUse I remember this being reported.
https://www.voanews.com/a/sout...
@dgurdasani1@AbundantLandUse我记得有人报道过这件事。
https://www.voanews.com/a/sout...
@justthefacts85 https://twitter.com/FDA_Drug_I...
FDA announces sotrovimab is no longer authorized for #COVID19 use at this time in CT, ME, MA, NH, RI, VT, NJ, NY, PR, and USVI based on new data showing that sotrovimab is unlikely to be effective against the Omicron BA.2 sub-variant: https://go.usa.gov/xz7Gd https://t.co/zUIYc3DBJK
发表时间:4年前 作者:FDA Drug Information @FDA_Drug_Info@公正的事实85https://twitter.com/FDA_Drug_I...
FDA宣布,根据新数据显示索曲单抗不太可能对奥米克罗BA有效,索曲单抗目前不再被授权在CT、ME、MA、NH、RI、VT、NJ、NY、PR和USVI使用。2子变量:https://go.usa.gov/xz7Gd https://t.co/zUIYc3DBJK